Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), ("Kiora" or the "Company") announced their abstract of a preclinical study of KIO ...
Hosted on MSN24d
Novel mRNA-based therapy offers hope for patients with proliferative vitreoretinopathy Mass Eye And Ear-Le...A new preclinical study by Mass Eye and Ear investigators showed that a novel mRNA-based therapy may be able to prevent blindness and scarring from proliferative vitreoretinopathy (PVR ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback